Iraq vs Oman: HIV-positive TB patients on ART (antiretroviral therapy)
Iraq
100.0%
in 2021
Oman
100.0%
in 2024
Iraq rank
1st
Oman rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Iraq
- Oman
How they compare
Iraq currently reports 100.0% against 100.0% in Oman, a difference of 0.0%.
The two have swapped places 2 times across 5 shared years of data; in 2011 it was Oman ahead.
Iraq ranks 1st and Oman ranks 1st of 144 countries.
Oman has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iraq | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.7% | 82.7% | 16.0% | Oman |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Iraq or Oman?
- Iraq, at 100.0% against 100.0% in Oman as of 2021.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Iraq and Oman?
- 0.0%, with Iraq ahead.
- How many years of comparable data are there for Iraq and Oman?
- 5 years are reported by both, from 2011 to 2021.
- How do Iraq and Oman rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Iraq ranks 1st and Oman ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.